How syngenta bet on automating data while others still transcribe by hand

How syngenta bet on automating data while others still transcribe by hand

While the agricultural industry debates artificial intelligence strategies at conferences, syngenta made an operational decision that says more than any PowerPoint presentation: it hired tetrascience to eliminate manual data transcription in its crop protection division. This is not a lab pilot or an unfunded proof of concept. It is a bet on turning years of fragmented chromatography and mass spectrometry data into a centralized, standardized, algorithm-ready asset.

Tomás RiveraTomás RiveraApril 22, 20267 min
Share

syngenta bet on automating data where others are still transcribing by hand

while the agricultural industry debates artificial intelligence strategies at conferences, syngenta made an operational decision that says more than any powerpoint presentation: it hired tetrascience to eliminate manual data transcription in its crop protection division. this is not a laboratory pilot or a proof of concept without a budget. it is a bet on turning years of fragmented chromatography and mass spectrometry data into a centralized, standardized, and algorithmically processable asset.

the chosen platform, tetra os, operates through what tetrascience calls the tetra scientific data foundry: an infrastructure layer that takes raw data from disparate analytical instruments, normalizes it, and deposits it in a format that artificial intelligence systems can consume directly. what was previously a manual copy-and-paste process between systems becomes a continuous flow. the practical result is a unified "scientific memory" where researchers stop searching for data and start using it.

the invisible cost of data silos in r&d

syngenta did not arrive at this decision from scratch. its recent track record in scientific digitalization shows a deliberate progression. the synapse platform, developed with datavid, had already indexed 16 million documents from 22 different sources, including records dating back to before 1960, and delivered measurable results: 30 to 40% less time spent on data retrieval by scientists and regulatory teams, and a reduction of 20 to 30% in regulatory compliance risk through automated filtering of sensitive information. eliminating duplicate studies generated savings of thousands of dollars per project.

that precedent defines the threshold of expectations for tetra os. syngenta already knows that automating data access generates measurable returns. the question that this move answers is not whether automation works, but how far it can scale. synapse solved the problem of semantic search. tetra os attacks the prior problem in the chain: the generation and standardization of data at the source, before anyone needs to search for it.

here is the mechanics that few coverage outlets are pointing out: data from analytical instruments such as chromatographs and mass spectrometers is output in proprietary formats that vary by manufacturer, software version, and laboratory configuration. every time a scientist needs to compare results across instruments or transfer data to a modeling tool, someone, somewhere, performs a manual conversion. that is not a support process. it is a bottleneck that slows down every r&d decision. multiplied across hundreds of researchers in multiple geographies, the cumulative cost in time and transcription errors is structural, not marginal.

what the deployment of "sciborgs" reveals about the implementation strategy

tetrascience includes in the agreement the deployment of what they call tetra sciborgs: teams of engineer-scientists who work within the client organization during implementation, adoption, and continuous improvement. this detail is not cosmetic. it is the most honest signal of where these projects typically fail.

the majority of data automation projects in r&d die in the gap between the installed platform and the operational habits of the scientific team. new software does not change how a researcher with 15 years of experience documents their trials. real adoption requires someone who understands both the scientific process and the data architecture, and who can sit down in the laboratory to redesign concrete workflows. tetrascience is betting that this in-person accompaniment is part of its differential value proposition, not an add-on service.

for syngenta, this also has implications for how to evaluate the return on investment. it is not just a question of whether the platform works technically; the real measure is the speed of effective adoption by the teams. if the sciborgs manage to anchor usage within the real workflows of the scientists during the first few months, the system builds a positive spiral: more quality data enters the foundry, the downstream models become more useful, and decisions are made faster. if they do not succeed, syngenta ends up with another well-installed platform that nobody uses in a systematic way.

data automation as infrastructure for what is to come

this move carries greater weight when connected to syngenta's broader investment context. the company is building the biostar (biological sciences technology and research center) in jealott's hill, united kingdom, with an investment of 130 million dollars and capacity for 300 scientists, with full operation projected for 2028. in parallel, in march 2026, it signed an agreement with quantumbasel to explore quantum computing applied to the modeling of molecular interactions in crop protection products.

neither of these two bets generates returns if the data that feeds them continues to be fragmented, inconsistent, or trapped in proprietary formats. quantum computing for molecular modeling needs clean and structured molecular data. the 300 scientists at biostar will produce volumes of analytical data that, without standardization infrastructure, will simply accumulate in new silos. tetra os, in that context, is not an operational efficiency project. it is the data infrastructure on which syngenta plans to mount its most advanced capabilities over the next three to five years.

for tetrascience, closing syngenta as a client has a value that transcends the contract itself. precision agriculture and crop protection share data challenges that are almost identical to those of the pharmaceutical industry and biotechnology: heterogeneous instruments, proprietary data, strict regulatory requirements, and the need for traceability. syngenta operates as a reference case for these adjacent markets.

the pattern that emerges from this move is clear: the organizations that will compete in high-complexity scientific r&d will not differentiate themselves by having better laboratory instruments than their rivals. everyone has access to the same analytical technology. the operational advantage will reside in who converts the data from these instruments into decisions more quickly. sustainable leadership in innovation is not built by those who have the most ambitious ideas on paper, but by those who first eliminate the friction that prevents today's data from feeding tomorrow's decisions.

Share

You might also like